论文部分内容阅读
本文报导用利福平450毫克/日并用一般抗结核药物治疗初、复治肺结核六个月,痰菌阴转持续三个月以上者,作为利福平远期疗效规察的对象。初治46例,复治230例,共随访五年,以考核利福平对痰菌的作用及用药时间。初治病例中40例有空洞。复治病例年龄大部分在40岁以上,大多数病例有空洞。这类病例,以往均曾用过其他抗结核药物,用过3种的40例,4～5种70例,6种以上120例。对一般抗结核药物无耐药性的20例,对1种抗结核药物有耐药性27例,对2～3种有耐药性109例,对4～5种有耐药性65例,对6种以上有耐药性5例,未检
This article reports the use of rifampicin 450 mg / day and general anti-TB drugs for primary and retreatment tuberculosis six months, sputum negative conversion for more than three months, as rifampicin long-term efficacy of the object. 46 cases of initial treatment, rehabilitation of 230 cases were followed up for a total of five years to assess the role of rifampin sputum bacteria and medication time. 40 cases of newly diagnosed cases are empty. The majority of retreatment cases are over the age of 40, with most cases being empty. These cases, in the past have used other anti-TB drugs, used three kinds of 40 cases, 4-5 kinds of 70 cases, more than 6 kinds of 120 cases. There were 20 cases with no resistance to common anti-TB drugs, 27 cases with one kind of anti-tuberculosis drugs, 109 cases with 2 to 3 kinds of resistance, 65 cases with 4 to 5 kinds of resistance, More than 6 kinds of resistance in 5 cases, not seized